Enthusiasm for intralesional BCG therapy waned following reports
of anaphylactic reactions; disseminated BCG mortality [7]; and, in our own research, the
occurrence of punctate
abscesses in more than two - thirds
of treated patients, as well as failure to impact outcomes.